Empagliflozin trials for Type 2 diabetes

All Empagliflozin trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Empagliflozin for Type 2 diabetes

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
  NCT07064473 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1147 locations
• Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
  NCT07093476 · Phase: Phase 3 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.
  NCT04602754 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus
  NCT05028140 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
  NCT05164263 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 6 locations

Common questions

How many trials study Empagliflozin for Type 2 diabetes?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.